KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Restructuring Costs (2016 - 2025)

Historic Restructuring Costs for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $47.0 million.

  • Merck's Restructuring Costs fell 1607.14% to $47.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $727.0 million, marking a year-over-year increase of 4143.97%. This contributed to the annual value of $309.0 million for FY2024, which is 4841.4% down from last year.
  • Merck's Restructuring Costs amounted to $47.0 million in Q3 2025, which was down 1607.14% from $560.0 million recorded in Q2 2025.
  • In the past 5 years, Merck's Restructuring Costs ranged from a high of $560.0 million in Q2 2025 and a low of $47.0 million during Q3 2025
  • Its 5-year average for Restructuring Costs is $135.9 million, with a median of $94.0 million in 2022.
  • As far as peak fluctuations go, Merck's Restructuring Costs plummeted by 8215.49% in 2022, and later surged by 60000.0% in 2025.
  • Quarter analysis of 5 years shows Merck's Restructuring Costs stood at $174.0 million in 2021, then crashed by 71.84% to $49.0 million in 2022, then skyrocketed by 420.41% to $255.0 million in 2023, then crashed by 80.0% to $51.0 million in 2024, then dropped by 7.84% to $47.0 million in 2025.
  • Its Restructuring Costs was $47.0 million in Q3 2025, compared to $560.0 million in Q2 2025 and $69.0 million in Q1 2025.